Role of Rebates in Cutting Drug Costs | OAS Episode 176
Our American States
The high cost of prescription drugs is a focus for legislators across the country. Over the past year, this podcast has talked with lawmakers about controlling the price of insulin, bringing more transparency to the work of pharmacy benefit managers, increasing efforts to gather drug cost data and creating drug affordability boards.
In this fourth and final episode of the series, we sat down with Rep. Iman Jodeh (D-Colo.) to talk about legislation passed in her state, requiring pharmaceutical benefit managers and health plans to demonstrate how rebates collected for manufacturers are used to reduce health insurance premiums. The legislation also requires certain state regulated health plans to implement co-payment only structures for all cost sharing tiers in their drug formularies.
Also joining for this episode is Colleen Becker of NCSL. She tracks legislation related to prescription drug costs and was instrumental in putting this series of podcasts together. She talked about the different types of legislation passed in 2022 and what we can expect to see coming out legislatures on this issue in the future.
Resources
- OAS Episode 176 Transcription
- Prescription Drug State Bill Tracking Database | 2015-Present
- Rep. Iman Jodeh, Colorado General Assembly
Previous Episodes in the Series